Meridian Energy generates, trades and retails electricity from renewable energy sources such as wind and hydro power.

Headquartered in Wellington, New Zealand, and with a presence in the UK, Meridian supplies electricity to homes, businesses and farms. Meridian’s existing power generation facilities include four wind farms across New Zealand and six hydro stations within the Waitaki hydro scheme which provides 16% of New Zealand’s electricity supply. Meridian further leveraged their renewable technology by designing and building a wind farm to power the Scott Base and McMurdo research stations on Ross Island in Antarctica. 

Meridian is engaged in several new renewable electricity generation projects, with a target to build seven large-scale renewables and storage projects across New Zealand by 2030. These projects range from additional wind farms in Hawke’s Bay to an energy park comprised of battery storage and additional solar farms in Whangārei. Across its existing and pipeline projects, Meridian is contributing towards New Zealand’s target of 100% renewable electricity generation by 2030. 

SDG contribution

What are SDGs?
 

	Affordable and clean energy
	Climate action

Visit website  

Main Sequence is a deep tech venture capital fund focused on tackling the world’s biggest challenges by turning scientific discoveries into future industries. Founded by the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency and one of the largest and most diverse scientific research organisations in the world, Main Sequence has invested over $1 billion across three funds since its establishment in 2017.  

Main Sequence invests in six themes: decarbonising the planet, reaching humanity-scale healthcare, feeding 10 billion people, supercharging industrial productivity, enabling the next technology leap, and bridging the gap to space.

Deep tech investing includes backing technologies from very early stage, and in some cases finding novel research and building companies from scratch. The approach is designed to pair deep scientific knowledge with the industry expertise and capital funding to build entire industries and ecosystems around solving global-scale challenges.  

Positive contribution 

Visit website  

This Australian-headquartered medical devices company with a global reach provides bone conduction implants for people with conductive hearing loss, mixed hearing loss and single-sided deafness. Cochlear is particularly known for its cochlear implants, with products that incorporate cutting edge technology, offering significant improvements in hearing for individuals with severe to profound hearing loss.  

The World Health Organisation estimates that over 466 million people suffer from disabling hearing loss globally, and this number is growing with the rise and ageing of the global population. Hearing loss is associated with cognitive decline, social isolation and depression.

Cochlear commissions animal testing in the development of their devices, and although they use some other forms of testing, we are seeking to influence the company to do more to minimise the use and suffering of animals.  

Positive contribution 

Visit website